Related Experiment Video
Updated: Aug 5, 2026

12:23
Phosphopeptide Enrichment Coupled with Label-free Quantitative Mass Spectrometry to Investigate the Phosphoproteome in Prostate Cancer
Published on: August 2, 2018
Endogenous Phosphopeptidomics Analysis by Using Mesoporous IMAC Materials
Ci Wu1,2, Bing Liu1, Junfeng Ma3
1School of Chemistry and Chemical Engineering, Liaoning Normal University, Dalian, 116029, China.
Methods in Molecular Biology (Clifton, N.J.)
|August 1, 2026
Summary
This study introduces a new method using Zirconium (IV)-grafted mesoporous beads for enriching phosphopeptides. This technique improves the detection of low-abundance endogenous phosphopeptides in serum for biomarker discovery.
Area of Science:
- Biochemistry
- Proteomics
- Analytical Chemistry
Background:
- Endogenous phosphopeptide analysis is vital for understanding cellular signaling and disease.
- Phosphoproteomics has advanced, but endogenous phosphopeptidomics faces challenges due to abundant non-modified peptides.
- Detecting low-abundance phosphopeptides in complex biological samples like serum is difficult.
Purpose of the Study:
- To present a protocol for selective phosphopeptide enrichment from serum.
- To overcome the limitations of current endogenous phosphopeptidomics methods.
- To enhance the sensitivity and specificity of detecting endogenous phosphopeptides.
Main Methods:
- Utilized Zirconium (IV)-grafted mesoporous beads for selective phosphopeptide enrichment.
- Employed high-resolution nanoRPLC-MS/MS for sensitive peptide analysis.
- Applied the protocol to complex biological matrices, specifically serum samples.
Main Results:
- Successfully enriched low-abundance endogenous phosphopeptides from serum.
- Demonstrated enhanced sensitivity and specificity in phosphopeptide detection.
- The developed method addresses challenges posed by abundant non-modified peptides.
Conclusions:
- The Zirconium (IV)-grafted mesoporous bead approach offers a significant improvement for endogenous phosphopeptidomics.
- This method facilitates the identification of potential biomarkers for disease monitoring.
- The protocol enables more effective analysis of cellular signaling alterations in vivo.

